# Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain

> **NCT02821169** · PHASE3 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 184 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ropivacaine
- **DRUG:** saline solution 0.9%

## Key facts

- **NCT ID:** NCT02821169
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02821169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02821169, "Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02821169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*